The Application of Sterile Water to the Skin of Extremely Low Birth Weight (ELBW) Infants

Sponsor
George Washington University (Other)
Overall Status
Completed
CT.gov ID
NCT02052284
Collaborator
(none)
30
1
2
48
0.6

Study Details

Study Description

Brief Summary

Extremely low birth weight infants have significant water loss through their skin immediately after birth. This significant fluid loss is because they have large amounts of fluids, have immature skin and large surface area. Loss of fluids is associated with many complications. The investigators hypothesize that application of sterile water to the skin of these infants is associated with decreased fluid requirements in the first week of life , improve skin integrity and decrease some complications of prematurity.

Condition or Disease Intervention/Treatment Phase
  • Other: Sterile water application
N/A

Detailed Description

Extremely low birth weight (ELBW) infants have significant transepidermal water loss immediately after birth. This significant fluid loss is related to proportionally large extracellular pool of fluids, the immaturity of the skin barrier, and the relatively large surface area exposed to evaporation. Water depletion in this population is associated with development of significant electrolyte imbalance in the form of hypernatremia, hyperkalemia, hyperglycemia and hyperosmolarity. In order to compensate for these losses, clinicians have to progressively increase fluid intake. Excessive fluid intake in the first days of life is associated with worsening patent ductus artriosus (PDA), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD) and mortality. Also skin integrity is important to protect against skin infection and secondary sepsis. Based on recent studies and relevant data, the risk of sepsis in ELBW is up to 40% nationwide, but only about 25% at GWUH Water application is a benign treatment that is routinely applied to the skin of premature babies and was shown to decrease skin colonization. The current practice at GWUH is to clean the bodies of premature infants using a piece of damp cloth with warm water. This is performed at birth and consequently every other days. The study group will receive more frequent and standardized applications. The investigators hypothesize that application of sterile water in ELBW infants is associated with decreased fluid requirements in the first week of life. As a secondary outcome, the investigators hypothesize that sterile water application is associated with improved skin integrity, decreased incidence of BPD with no increased incidence of skin or systemic infections.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Prevention
Official Title:
The Application of Sterile Water to the Skin of Extremely Low Birth Weight (ELBW) Infants
Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Dec 1, 2017
Actual Study Completion Date :
Dec 31, 2017

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

The control group will receive standard skin care of the NICU, which does not include specific measures to modulate skin-barrier function.The current practice at GWUH NICU is that nurses clean the bodies of newborns less than 1000 grams using a piece of damp cloth with warm water. This is performed at birth and consequently every other days.

Experimental: Water wash

The study group will undergo a protocol of sterile water application in addition to routine skin care of the NICU. The study group will receive more frequent and standardized applications. A commercially sterile water bottle (EnfamilĀ® Water) will be kept inside the isolette, to be maintained at isolette temperature, and will be changed on a daily basis. Nurses use sterile gloves as a routine for care of ELBW infants. A 2 inches x 2 inches sterile gauze will be soaked in sterile water and gently applied to all skin of the baby excluding umbilical cord and IV lines sites. This procedure will be repeated every 4 hours with routine patient care for the first 1 week of life.

Other: Sterile water application
Nurses are trained in proper dispensing and application of water in a sterile gentle way that will minimize shear force on the skin, risk for skin injury, and the potential for spread of fecal flora.

Outcome Measures

Primary Outcome Measures

  1. Daily fluid intake (ml/kg/day) [First 7 days of life]

    The primary outcome is daily fluid requirements in the first week of life. Daily fluid requirements from Day1 to Day7 will be compared between intervention and control groups.

Secondary Outcome Measures

  1. Skin Score [First 7 days of life]

    Neonatal Skin Condition Scale (NSCS) is a validated skin score used in the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) and the National Association of Neonatal Nurses (NANN) neonatal skin care evidence-based practice project. Score ranges from 3 to 9, with 9 being the worse

  2. Peak total bilirubin (mg/dl) [Participants will be followed for the duration of hospital stay, an expected average of 16 weeks]

  3. Incidence of significant PDA [Participants will be followed for the duration of hospital stay, an expected average of 16 weeks]

    Defined as PDA requiring treatment either medical or surgical

  4. Incidence of NEC [Participants will be followed for the duration of hospital stay, an expected average of 16 weeks]

    Necrotizing Enterocolitis (NEC): defined as stages II or III

  5. Incidence of BPD [Participants will be followed for the duration of hospital stay, an expected average of 16 weeks]

    Bronchopulmonary dysplasia (BPD), defined as O2 requirement at 36 weeks post menstrual age (PMA)

  6. Length of stay (days) [Participants will be followed for the duration of hospital stay, an expected average of 16 weeks]

  7. Incidence of culture proved sepsis [Participants will be followed for the duration of hospital stay, an expected average of 16 weeks]

    Culture proved sepsis

  8. Incidence of change in microbiological skin colonization [First week of life]

    Change in microbiological skin colonization by skin swab between day one and day 7 of life.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 24 Hours
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Extremely Low Birth Weight (less than 1000 grams at birth), and

  2. Less than 24 hours of life

Exclusion Criteria:
  1. Major congenital anomalies

  2. Malformations or other surgical emergencies requiring immediate transfer.

  3. Major skin abnormalities

Contacts and Locations

Locations

Site City State Country Postal Code
1 The George Washington University Hospital NICU Washington District of Columbia United States 20037

Sponsors and Collaborators

  • George Washington University

Investigators

  • Principal Investigator: Mohamed El-Dib, MD, The George Washington University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mohamed ElDib, Assistant Professor of Pediatrics and of Neurology, George Washington University
ClinicalTrials.gov Identifier:
NCT02052284
Other Study ID Numbers:
  • 071319
First Posted:
Feb 3, 2014
Last Update Posted:
Jan 23, 2018
Last Verified:
Jan 1, 2018
Keywords provided by Mohamed ElDib, Assistant Professor of Pediatrics and of Neurology, George Washington University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 23, 2018